Subsequent chemotherapy improves survival outcome in advanced non-small-cell lung cancer with acquired tyrosine kinase inhibitor resistance.

Source:http://linkedlifedata.com/resource/pubmed/id/20085868

Download in:

View as

General Info

PMID
20085868